← Back to news
Y

Yahoo Finance

Will Nvidia Stock Soar After Aug. 26? Here's What History Shows.

Y

Anthropic Has a $65 Billion Run Rate. Buy These Stocks to Profit From It.

Y

U.S. Treasury Yields Fall, Dollar Rises

Y

BlackRock Says the Long-Term Investment Thesis for Bitcoin Remains Intact. Is Bitcoin Now a Buy?

Y

Shares dip on pressure from technology; yields and oil fall

Y

XRP ETF Inflows Hit $1.55 Billion Record Amid 70% Price Surge

Y

One Sentence in the Fed Meeting Minutes Is Nightmare Fuel for Fed Chair Kevin Warsh and the Stock Market

Y

Global Bond Yields Fall on Declining Oil, Prospects of Further Treasury Steps to Tackle Recent Highs

Y

Samsung Falls 8.7% After Record $79 Billion Payout Disappoints

Y

XRP News: Price Rally, Take Profit or Let It Run?

Y

ICYMI: Trump’s Stock Trades

Y

Nvidia Earnings, Jackson Hole: What to Watch This Week

Y

I've Covered Semiconductors for Years. Nvidia Is My No. 1 Pick Heading Into 2027.

Y

Stock market today: S&P 500, Nasdaq slip as tech stocks sag, US-Canada trade spat escalates

Y

Prediction: UPS Dividend Remains Frozen Through 2027

Y

Japanese Yen Has Plenty of Scope to Fall

Y

Gold Above $4,700 Ahead of Inflation Data, Fed Chair Speech

Y

Oil Falls Ahead of Bessent’s Press Conference

Y

Exxon Eyes Shell’s $8 Billion U.S. Chemicals Business

Y

Equinor and Uniper Sign 15-Year Gas Supply Deal for Germany

Y

World shares decline as bond market pressure persists, and Iran's rial sinks against the dollar

Y

T. Rowe Price Bets Big on Fixed Income With F/m Deal

Y

Why Passive Inflows May be Pulling Down Active Fund Performance

Y

Dimensional, Allspring Latest Firms to Tack on ETF Share Classes

Y

Oil slips ahead of US announcement of new sanctions on Iran

Y

Walmart stock price target reset by JPMorgan after earnings

Y

Ampol Profit Surges as Middle East Disruption Boosts Refining Margins

Y

Alibaba shares fall 8% after $10 billion Hong Kong share sale

Y

Gold, silver rally off ugly crash, but investors remain on edge

Y

Alibaba shares slide after $10.2 billion AI share sale offered at sharp discount

Y

AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated?

Y

Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

Y

Duos Technologies’ AI Transformation Has Wall Street’s Attention. Here’s How Big This $300 Million Market Cap Company Could Get.

Y

Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business?

Y

Samsung Electronics shares skid as record shareholder returns disappoint

Y

Gilead’s Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off?

Y